Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rushnet Inc (OP: RSHN )

0.0002 UNCHANGED
Streaming Delayed Price Updated: 10:50 AM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 0.0002
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0002
Today's Range 0.0002 - 0.0002
52wk Range 0.0001 - 0.0022
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
heliosDX Succumbs to Unprecedented Challenges in the Healthcare Market
Via ACCESSWIRE
Rushnet, Inc Announces Agreement with Ehave for Mental Health Lab Testing
Via ACCESSWIRE

Performance

YTD
-85.71%
-85.71%
1 Month
N/A
N/A
3 Month
-71.43%
-71.43%
6 Month
-66.67%
-66.67%
1 Year
-88.89%
-88.89%

More News

Read More
Rushnet, Inc / Announces FINRA Denial of Planned Spin-Off
Via ACCESSWIRE
Rushnet, Inc Investment Partners Remain Confident in heliosDX Overall Strategy; Restructures Debt
Via ACCESSWIRE
heliosDX and Rushnet, Inc to Host “Off The Cuff” via Twitter Spaces
Via ACCESSWIRE
CEO, COO, and Directors Reduce Salaries for heliosDX, a Subsidiary of Rushnet, Inc
Via ACCESSWIRE
Rushnet, Inc - Adjusting Business Structure in Preparation for the Spinout of heliosDX
Via ACCESSWIRE
This Company Is Preparing To Rollout CBD And Wellness Patches As 'A Healthy Alternative To Traditional Oral Aids And Supplements'
Via Benzinga
Rushnet, Inc's Subsidiary, heliosDX To Launch Wellness Patches for General Well-Being
Via ACCESSWIRE
Rushnet's Subsidiary heliosDX Commences National Marketing Campaign for Monkeypox Virus Testing Services
Via ACCESSWIRE
Rushnet's Subsidiary heliosDX Launches Human Monkepox Virus Testing, Available Immediately
Via ACCESSWIRE
heliosDX Responds To Growing Concerns About Monkeypox By Adding Testing To Its Infectious Disease Panel
Via ACCESSWIRE
heliosDX Stands Against WellMed; Fighting For Patient, Physician and Independent Laboratory Rights
Via ACCESSWIRE
Rushnet, Inc. and heliosDX Launch AutoUA(R) Testing to Enhance Patient Care and Help Prevent Kidney Disease Among Other Conditions including UTI
From RushNet, Inc.
Via AccessWire
Rushnet, Inc Current Status Update on the Progress Towards heliosDX Spinout and Capital Raise Through Tier 2 Regulation A
From RushNet, Inc.
Via AccessWire
Rushnet, Inc Pursues Spinoff of HeliosDX, Dividend
From RushNet, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Rushnet, Inc PCAOB Audit Complete With Clean Opinion, Paving the Way for the Next Major Milestones of the 15 Month Plan
From RushNet, Inc.
Via AccessWire
Rushnet, Inc Announces Debt Restructuring to Greatly Increase Profitability and Cash Flow
From RushNet, Inc.
Via AccessWire
Rushnet, Inc. and its Subsidiaries Persist in the Climb Towards its Major Milestones and Goals
From RushNet, Inc.
Via AccessWire
Rushnet, Inc and its Subsidiaries heliosDX and Grandeza Healthcare Provide an Update on the Ongoing PCAOB Accredited Audit
From RushNet, Inc.
Via AccessWire
Rushnet, Inc and its Subsidiaries heliosDX and Grandeza Healthcare Engaged Somerset CPAs and Advisors to Complete Audits
From RushNet, Inc.
Via AccessWire
Rushnet, Inc Through Its Subsidiaries heliosDX and Grandeza Healthcare Achieve Major Financial Milestone
From RushNet, Inc.
Via AccessWire
RushNet, Inc (RSHN) heliosDX, Grandeza Healthcare issues a Letter to Shareholders
From RushNet, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Regulatory
heliosDX to Present at the Emerging Growth Conference on Wednesday October 27, 2021; Invites Institutional and Individual Investors
From RushNet, Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures COVID-19 Legal Regulatory
RushNet, Inc (RSHN), its Subsidiaries heliosDX and Grandeza Healthcare Announce Major Roadmap Spanning 15 Months
From RushNet, Inc.
Via AccessWire
Topics Artificial Intelligence Regulatory Compliance
Exposures Artificial Intelligence COVID-19 Legal
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.